Categories: News

EquiLend Acquires Finadium, Expanding Presence in Securities Finance Research & Consulting

Finadium to continue operating independently as a subsidiary of EquiLend

- Advertisement -

NEW YORK, May 12, 2026 /PRNewswire/ — EquiLend, a global leader in securities finance technology, data, and analytics, today announced the acquisition of Finadium, a premier research and consultancy firm serving the securities finance, repo, collateral, and capital markets infrastructure industries.

- Advertisement -

Finadium will operate as an independently functioning subsidiary of EquiLend. Its research will remain editorially independent, and Josh Galper will remain as leader of the firm, overseeing its day-to-day operations.

- Advertisement -

“This acquisition deepens our ability to serve clients across the securities finance industry,” said Rich Grossi, CEO of EquiLend. “Finadium has built an exceptional reputation for impartial, best-in-class thinking and consulting, and we’re committed to preserving that independence while investing to broaden and expand its consultancy services, enhancing the support available to meet the evolving needs of all market participants.”

- Advertisement -

“We are very pleased to join the EquiLend family,” said Josh Galper, leader of Finadium. “The markets are changing fast, and developing our franchise in partnership with EquiLend will support the entire funding and financing industry. We’re excited to maintain our editorial independence while delivering world-class market intelligence and consulting to both EquiLend clients and a diverse range of market participants globally.”

- Advertisement -

Finadium serves a global client base with research reports, data products, and consulting services focused on securities finance, repo, prime brokerage, and related capital markets topics. The acquisition expands EquiLend’s access to market intelligence, consultancy capabilities, and reinforces its position as a comprehensive resource for the global securities finance community.

- Advertisement -

About EquiLend

- Advertisement -

EquiLend is a global financial technology firm offering Trading, Workflow Tools, Data & Insights, and Digital Solutions for the securities finance industry. With offices in North America, EMEA and Asia-Pacific, EquiLend operates across various jurisdictions worldwide, adhering to the highest regulatory standards.

- Advertisement -

The company is committed to excellence and innovation and is consistently recognized for its contributions to the industry. EquiLend is Great Place to Work Certified™ in the U.S., UK, Ireland and India and has been awarded Global Data Provider of the Year and Regulatory Solution of the Year in the Securities Finance Times Industry Excellence Awards 2025.

- Advertisement -

For more information, please visit www.equilend.com.

- Advertisement -

About Finadium

- Advertisement -

Finadium is a research and consulting firm focused on funding, financing and infrastructure for capital markets. In its research practice, the firm assists plan sponsors, asset managers, brokers, custodians, hedge funds and technology firms with understanding the market and in maximizing the effectiveness of their resources. Finadium market intelligence is available on a subscription basis. Finadium also conducts consulting assignments on vendor selection, marketing and product development.

- Advertisement -

For more information, please visit our website at www.finadium.com and follow Finadium on LinkedIn. Finadium publishes daily News & Opinion on our website.

- Advertisement -

EquiLend Media Contact:
media@equilend.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/1060364/EquiLend_Logo.jpg 

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/equilend-acquires-finadium-expanding-presence-in-securities-finance-research–consulting-302768980.html

- Advertisement -

Recent Posts

MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe…

5 hours ago

Boston Dental Named The Best Dentist in Boston

Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services June 19,…

5 hours ago

Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities’ first inpatient behavioral health treatment and recovery facility

YAKIMA, Wash., June 19, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that the Columbia…

5 hours ago

TheDoseReport Announces Which GLP-1 is Best? Semaglutide and Tirzepatide

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com Releases Analysis: Which GLP-1 is Best?…

13 hours ago

From Living Rooms to Garages: GARVEE Expands Affordable Cooling Solutions for Summer 2026

ONTARIO, Calif., June 21, 2026 (GLOBE NEWSWIRE) -- GARVEE launches the 2026 Summer AC Campaign…

13 hours ago

Crypto News: AlphaPepe Expands Listings With BiFinance CEX Deal as Bitcoin Price Prediction Eyes $250,000

MONACO, June 20, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

13 hours ago